skip to content
Primary navigation


DrugHemangeol™ (propranolol HCl oral solution) [Pierre Fabre Pharmaceuticals, Inc.]

November 2014

Therapeutic area - Beta-adrenergic blocking agents

FDA approved indications

Hemangeol oral solution is a beta-adrenergic blocker indicated for the treatment of proliferating infantile hemangioma requiring systemic therapy.

Approval criteria

  • Patient has a diagnosis of proliferating infantile hemangioma AND
  • Patient has tried and failed the generic propranolol HCL oral solution

Approvals will not be granted for any other diagnosis.


MHCP Provider Call Center 651-431-2700 or 800-366-5411

back to top